Phosphagenics Limited announced the appointment of Dr. Ross Murdoch as CEO. Dr. Murdoch has more than 25 years of experience leading and managing the strategic, scientific and operational aspects of product research, development and commercialization across the healthcare, biotechnology and pharmaceutical Industries. Dr. Ross Murdoch has acted in many senior roles in both the biotechnology and pharmaceutical industries, including in more recent times the following: Senior Vice President at Shire Pharmaceuticals, responsible for founding and building the Emerging Products Business and the Hematology Business, as well as managing the move of the Specialty Pharmaceutical Business to Switzerland; President and COO of Prana Biotechnology Limited (Australia) where he played a key role in a number of capital raisings and Prana's NASDAQ listing.

Dr. Murdoch is relocating from the USA to Melbourne to take up this role. The appointment is on an ongoing basis and commences with effect from 12 January 2015.